DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Allegra (Fexofenadine) - Adverse Event Reports - Hospitalization - Blood Creatine Phosphokinase Increased

 



Index of reports > Cases resulting in hospitalization (23) > Cases with Blood Creatine Phosphokinase Increased (2)

Below is the selection of adverse event reports related to Allegra (Fexofenadine) that includes cases resulting in hospitalization where reactions include blood creatine phosphokinase increased.

Adverse event in female receiving Allegra (Fexofenadine)

Reported by a physician from Japan on 2007-10-24

Patient: female, weighing 50.0 kg (110.0 pounds)

Adverse reactions / side effects: Asthma, Blood Creatine Phosphokinase Increased, Cardiac Failure, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Allegra
    Administration route: Oral
    Start date: 2007-05-31
    End date: 2007-06-19

Crestor
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2007-05-31
    End date: 2007-06-14

Relifen
    Administration route: Oral
    Start date: 2006-12-01

Spiriva
    Indication: Bronchitis Chronic
    Start date: 2007-05-31

Other drugs received by patient: Almeta; Aldactone; Famotidine; SM; Elieten; Lasix; Gosha-Jinki-GAN; Acardi; Solon; NU-Lotan; Bezatol SR; Uralyt-U; Restamin; Transamin; Hustagin; Meiact; Mohrus Tape; Urepearl; Nitropen; Buscopan; Epadel S; Frandol S; Antibiotic Preparations Acting Mainly ON Gram Positive BA



Adverse event in female receiving Allegra (Fexofenadine)

Reported by a physician from Japan on 2007-10-10

Patient: female, weighing 50.0 kg (110.0 pounds)

Adverse reactions / side effects: Asthma, Blood Creatine Phosphokinase Increased, Chest Discomfort, Cardiac Failure, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Allegra
    Administration route: Oral
    Start date: 2007-05-31
    End date: 2007-06-19

Crestor
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2007-05-31
    End date: 2007-06-14

Relifen
    Administration route: Oral
    Start date: 2006-12-01

Spiriva
    Indication: Bronchitis Chronic
    Start date: 2007-05-31

Other drugs received by patient: Almeta; Aldactone; Famotidine; SM; Elieten; Lasix; Gosha-Jinki-GAN; Acardi; Solon; NU-Lotan; Bezatol SR; Uralyt-U; Restamin; Transamin; Hustagin; Meiact; Mohrus Tape; Urepearl; Nitropen; Buscopan; Epadel S; Frandol S; Antibiotic Preparations Acting Mainly ON Gram Positive BA

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009